← Back to Search

Behavioural Intervention

Walking Program for High Blood Pressure

N/A
Waitlist Available
Led By Duck-chul Lee, PhD
Research Sponsored by Iowa State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women aged 65 years and above
Respiratory impairment as assessed by abnormal spirometry (a lung function test). Abnormal spirometric phenotypes include obstructive pattern, restrictive pattern, mixed obstructive/restrictive, and preserved ratio impaired spirometry (PRISm)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8-weeks
Awards & highlights

Study Summary

This trial will assess if an 8-week walking program can lower blood pressure in older adults with respiratory impairment, reducing their risk of CVD.

Who is the study for?
This trial is for inactive adults aged 65+ with respiratory issues and high blood pressure (systolic 120-159 mmHg), who are non-smokers, have a BMI <42kg/m2, and take fewer than 7,000 steps daily. They must be willing to increase their walking but can't join if they've had recent serious health events like stroke or heart attack, use oxygen supplements, or have mobility-limiting conditions.Check my eligibility
What is being tested?
The study tests whether an 8-week program of increased lifestyle walking lowers blood pressure in older adults with breathing problems. Participants will either follow the walking program or receive only health education about managing their condition.See study design
What are the potential side effects?
While there may not be direct side effects from increased walking or health education, participants should watch for any discomfort due to physical activity such as joint pain, fatigue, or shortness of breath.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
My lung function test shows I have breathing problems.
Select...
My blood pressure is between 120 and 159 mmHg, or I am on medication for high blood pressure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8-weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8-weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in systolic blood pressure
Secondary outcome measures
Feasibility of conducting the study
Other outcome measures
Change in SPPB performance
Change in arterial stiffness
Change in cognitive performance
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Increased lifestyle walking (intervention)Experimental Treatment1 Intervention
Intentional increase in daily steps: 3,000 extra steps/day, 5-days a week, 8-weeks total.
Group II: Health education only (control)Experimental Treatment1 Intervention
Health education and no intentional increase in baseline daily steps (but with the option to receive the intervention upon conclusion of the initial 8-weeks).

Find a Location

Who is running the clinical trial?

Iowa State UniversityLead Sponsor
59 Previous Clinical Trials
144,523 Total Patients Enrolled
Duck-chul Lee, PhDPrincipal InvestigatorIowa State University
2 Previous Clinical Trials
90 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there presently any opportunities for individuals to take part in this trial?

"As evidenced on clinicaltrials.gov, this medical experiment is not currently accepting applicants as it was recently updated on September 11th 2023. Despite the fact that there are no open slots for this trial, 1027 other trials have slots available for new participants right now."

Answered by AI

Who else is applying?

What site did they apply to?
Iowa State University
What portion of applicants met pre-screening criteria?
Met criteria
~19 spots leftby Apr 2025